Metaraminol 10mg/ml Solution for Injection or Infusion

Ülke: Birleşik Krallık

Dil: İngilizce

Kaynak: myHealthbox

Aktif bileşen:

metaraminol

Mevcut itibaren:

South Devon Healthcare NHS Foundation Trust

ATC kodu:

C01CA09

INN (International Adı):

metaraminol

Doz:

10mg/ml

Farmasötik formu:

Solution for injection or infusion

Uygulama yolu:

Intravenous use

Paketteki üniteler:

Pack size of 10 ampoules in an outer carton

Reçete türü:

POM - Prescription Only Medicine

Tarafından üretildi:

South Devon Healthcare NHS Foundation Trust

Terapötik grubu:

Adrenergic and dopaminergic agent

Terapötik endikasyonlar:

For the treatment of acute hypotension due to loss of vasoconstrictor tone as may occur during spinal anaesthesia and as an adjunct to accepted remedial procedures.

Yetkilendirme durumu:

Authorised

Yetkilendirme tarihi:

2015-07-06

Bilgilendirme broşürü

Ürün özellikleri

Metaraminol 10mg/mL Solution for Injection or Infusion
Summary of Product Characteristics Updated 14­Sep­2015 | Torbay Pharmaceuticals, South Devon Healthcare NHS
Foundation Trust
1. Name of the medicinal product
Metaraminol 10mg/mL Solution for Injection or Infusion.
2. Qualitative and quantitative composition
Each 1 mL of solution contains 10mg of metaraminol (as tartrate).
Excipients of known effect:
Sodium chloride
Sodium metabisulfite
Each 1 mL of solution contains 98.4 mmol (2.26 mg) sodium.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Solution for injection or infusion.
Glass ampoule containing a clear colourless solution with pH of 3.2 to 4.5 and osmolarity of 305mOsm/litre.
4. Clinical particulars
4.1 Therapeutic indications
For the treatment of acute hypotension due to loss of vasoconstrictor tone as may occur during spinal anaesthesia and
as an adjunct to accepted remedial procedures.
4.2 Posology and method of administration
_Method of Administration_
For intravenous use.
_Posology_
_Direct intravenous injection in grave emergencies: _0.5 ­5 mg (0.05­0.5 ml), followed by an infusion of 15­100 mg (1.5­10
ml) in 500 ml of infusion liquid.
Particular care should be taken to use the correct dose when injecting undiluted metaraminol.
_Intravenous Infusion:_ 15­100 mg (1.5­10.0 ml) in 500 ml Sodium Chloride Injection or Dextrose 5% Injection, adjusting
the rate of infusion to maintain the blood pressure at the desired level. Higher concentrations of Metaraminol have been
used when appropriate to the circumstances.
_Children:_ Metaraminol should not be used in children under 12 years of age.
_Use in the elderly: _The dosage may not require modification for elderly patients; however, geriatric patients may be
more sensitive to sympathomimetic�